KoreaMed, a service of the Korean Association of Medical Journal Editors (KAMJE), provides access to articles published in Korean medical, dental, nursing, nutrition and veterinary journals. KoreaMed records include links to full-text content in Synapse and publisher web sites.
Sarcopenia is defined as the loss of muscle mass and strength that occurs with aging. Although the etiology, pathogenesis, and diagnosis of sarcopenia are obscure, sarcopenia has been suggested to...
Qualitative research methodology has become more recognized and valued in diabetes behavioral research in recent years. Qualitative research is very rare in Korea, especially for diabetes; on the other hand,...
The ultimate goal of health care providers in treating chronic diseases such as diabetes is to prevent complications by providing symptom relief and delaying disease exacerbation rather than curing the...
Both obesity and diabetes impose not only individual health problems, but also large socioeconomic burdens worldwide. Obesity is a major cause of insulin resistance and diabetes and is closely linked...
Diabetes mellitus (DM) is a metabolic disease characterized by relative or absolute insulin deficiency. The hyperglycemic state of DM leads to changes in practically every cell type and organ of...
Diabetic nephropathy is a common complication of diabetes mellitus and is the leading cause of chronic kidney disease. Glycemic and blood pressure control constitute the main strategies of diabetic nephropathy...
Diabetes mellitus, which is a well-known chronic metabolic disorder with diverse complications, affects over 10% and up to nearly 20% of older adults; its prevalence is increasing rapidly. Fracture is...
According to a 2017 report from the Ministry of Food and Drug Safety of Korea (MFDS), the production quantity of health functional foods has increased by 29.9% from 1.133 trillion...
Dining out can be difficult for diabetics whose dietary choices are limited compared to healthy people. However, it is almost impossible to eat only at home in modern society, so...
BACKGROUND: Dapagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor, lowers blood glucose by reducing glucose reabsorption at the proximal renal tubule in an insulin-independent manner. We aimed to evaluate the...